122 results
Page 3 of 7
8-K
EX-99.1
uqqvt
12 May 22
Sema4 Reports First Quarter 2022 Financial Results and Business Highlights
4:15pm
424B3
q8m 0qbrb38pe
11 May 22
Prospectus supplement
5:06pm
8-K
EX-99.3
4h8zz
2 May 22
Katherine Stueland, former President and CEO of GeneDx, joins Sema4 as CEO and will serve on Board of Directors
8:30am
8-K
EX-99.1
cwimqv0
2 May 22
Katherine Stueland, former President and CEO of GeneDx, joins Sema4 as CEO and will serve on Board of Directors
8:30am
8-K
EX-10.1
cvf6f i8afc
2 May 22
Katherine Stueland, former President and CEO of GeneDx, joins Sema4 as CEO and will serve on Board of Directors
8:30am
DEFA14A
70nmiun
18 Apr 22
Additional proxy soliciting materials
5:11pm
424B3
16fw9jc
28 Mar 22
Prospectus supplement
5:15pm
POS AM
94gbmxirs0j 4m
21 Mar 22
Prospectus update (post-effective amendment)
5:19pm
424B3
r4dcic6vxck3
15 Mar 22
Prospectus supplement
5:25pm
DEFA14A
ebbewwl
15 Mar 22
Additional proxy soliciting materials
9:28am
424B3
ke8u8m9c
14 Mar 22
Prospectus supplement
5:23pm
8-K
EX-99.1
4lms t3z5vvfz6w6ii2
14 Mar 22
Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
4:18pm
8-K
EX-99.1
a4mjbxlslou8kj5lkeq
14 Mar 22
Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
4:17pm
DEFA14A
xrof4jt5s
11 Mar 22
Additional proxy soliciting materials
5:43pm
DEFA14A
e4y4p8x
8 Mar 22
Additional proxy soliciting materials
9:12am
DEFA14A
zj92j43 xt63lajw
22 Feb 22
Additional proxy soliciting materials
8:30am